Aureobasidium.org

patent 2023

Composition containing β-glucan and constipation-improving agent, immunostimulant and skin moisturizer using the composition – EU (European Patent No. 1602377)

Uchiyama H., Iwai A. · Japanese Patent Office
Research Archive
TL;DR — Key Findings
  • AP β-glucan composition combines constipation relief (prebiotic) and immune enhancement in one formulation.
  • Dual-action reflects β-glucan's integrated role in gut-immune health axis.
  • Multi-benefit formulations maximize the value of AP-glucan's prebiotic and immunostimulatory properties.

Abstract

Composition containing β-glucan and constipation-improving agent, immunostimulant and skin moisturizer using the composition – EU (European Patent No. 1602377)

Patent Details

Country of RegistrationEurope

Patent No.No.1602377Registration DateAugust 10, 2011

This patent is based on patents registered in Japan for “constipation remedy,” “skin moisturizer,” and “immunostimulant,” which were also applied for and approved overseas.

Summary

Summary

Background

This Japanese patent covers a β-glucan-containing composition that simultaneously addresses constipation improvement and immune enhancement through combined gastrointestinal and immune mechanisms.

Key Findings

The dual-action composition leverages AP β-glucan's prebiotic fiber properties (for constipation relief) and its immunostimulatory activity (for immune enhancement) in a single formulation. This reflects the integrated gut-immune health role of soluble dietary β-glucan.

Relevance to Aureobasidium Beta Glucan Research

Combining gastrointestinal and immune benefits in one formulation reflects AP-glucan's natural dual role as both a prebiotic fiber and immunostimulant, supporting its development as a comprehensive daily wellness ingredient.

Citation

Uchiyama H., Iwai A.. Composition containing β-glucan and constipation-improving agent, immunostimulant and skin moisturizer using the composition – EU (European Patent No. 1602377). Japanese Patent Office. 2023.

Study Details
Study Type
patent
Published
2023
Journal
Japanese Patent Office
Authors
Uchiyama H., Iwai A.
Important Notice

For scientific reference only. Not medical advice. Consult a qualified healthcare professional. See our Medical Disclaimer.